Oragenics Inc (OGEN)
0.274
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.2809
+0.01
(+2.52%)
After-Hours: 20:00
Oragenics Cash from Operations (Quarterly): -1.970M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.970M |
| June 30, 2024 | -1.544M |
| March 31, 2024 | -3.064M |
| December 31, 2023 | -1.102M |
| September 30, 2023 | -1.503M |
| June 30, 2023 | -2.577M |
| March 31, 2023 | -2.109M |
| December 31, 2022 | -2.433M |
| September 30, 2022 | -3.776M |
| June 30, 2022 | -3.383M |
| March 31, 2022 | -5.637M |
| December 31, 2021 | -2.485M |
| September 30, 2021 | -4.580M |
| June 30, 2021 | -2.078M |
| March 31, 2021 | -4.327M |
| December 31, 2020 | -3.632M |
| September 30, 2020 | -4.666M |
| June 30, 2020 | -4.833M |
| March 31, 2020 | -3.823M |
| December 31, 2019 | -3.936M |
| September 30, 2019 | -3.378M |
| June 30, 2019 | -3.488M |
| March 31, 2019 | -2.211M |
| December 31, 2018 | -2.978M |
| September 30, 2018 | -2.454M |
| Date | Value |
|---|---|
| June 30, 2018 | -2.281M |
| March 31, 2018 | -1.367M |
| December 31, 2017 | -1.359M |
| September 30, 2017 | -1.340M |
| June 30, 2017 | -1.765M |
| March 31, 2017 | -1.900M |
| December 31, 2016 | -1.964M |
| September 30, 2016 | -1.571M |
| June 30, 2016 | -1.92M |
| March 31, 2016 | -1.620M |
| December 31, 2015 | -1.662M |
| September 30, 2015 | -1.296M |
| June 30, 2015 | -0.9437M |
| March 31, 2015 | -1.288M |
| December 31, 2014 | -1.181M |
| September 30, 2014 | -1.098M |
| June 30, 2014 | -1.696M |
| March 31, 2014 | -1.584M |
| December 31, 2013 | -1.219M |
| September 30, 2013 | -1.964M |
| June 30, 2013 | -2.000M |
| March 31, 2013 | -1.581M |
| December 31, 2012 | -1.741M |
| September 30, 2012 | -1.178M |
| June 30, 2012 | -1.150M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.637M
Minimum
Mar 2022
-1.102M
Maximum
Dec 2023
-3.173M
Average
-3.224M
Median
Cash from Operations (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | -1.999M |
| Alaunos Therapeutics Inc | -0.781M |
| SELLAS Life Sciences Group Inc | -7.806M |
| Galectin Therapeutics Inc | -8.538M |
| Anavex Life Sciences Corp | -5.18M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 3.766M |
| Free Cash Flow | -7.682M |
| Free Cash Flow Per Share (Quarterly) | -0.3018 |
| Free Cash Flow Yield | -654.1% |